相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Hussin A. Rothan et al.
JOURNAL OF AUTOIMMUNITY (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials
Jeffrey I. Weitz et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome Results From a Prospective, Single-Center, Clinicopathologic Case Series
Sigurd F. Lax et al.
ANNALS OF INTERNAL MEDICINE (2020)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann et al.
ANNALS OF INTERNAL MEDICINE (2020)
COVID-19-associated immune thrombocytopenia
Gienke Bomhof et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
COVID-19 and Multiorgan Response
Sevim Zaim et al.
CURRENT PROBLEMS IN CARDIOLOGY (2020)
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines
Zhenguo Zhai et al.
THROMBOSIS AND HAEMOSTASIS (2020)
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
Behnood Bikdeli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Alex C. Spyropoulos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Songping Cui et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
Sharon E. Fox et al.
LANCET RESPIRATORY MEDICINE (2020)
Rivaroxaban in Peripheral Artery Disease after Revascularization
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Immune Thrombocytopenic Purpura in a Patient with Covid-19
Abrar-Ahmad Zulfiqar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study
Vincenzo Russo et al.
PHARMACOLOGICAL RESEARCH (2020)
Development of pulmonary embolism in a nonhospitalized patient with COVID-19 who did not receive venous thromboembolism prophylaxis
Ellen M. Uppuluri et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
COVID-19 mortality in patients on anticoagulants and antiplatelet agents
Helena Sivaloganathan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
A review of the main histopathological findings in coronavirus disease 2019
Walter O. Vasquez-Bonilla et al.
HUMAN PATHOLOGY (2020)
Coagulation abnormalities and thrombosis in patients with COVID-19
Marcel Levi et al.
LANCET HAEMATOLOGY (2020)
Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System
Seda Bilaloglu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
Alex C. Spyropoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
COVID-19 and hypercoagulability in the outpatient setting
Roger Emert et al.
THROMBOSIS RESEARCH (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Corrado Lodigiani et al.
THROMBOSIS RESEARCH (2020)
Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases
Siri Overstad et al.
THROMBOSIS RESEARCH (2020)
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial
Stefano Barco et al.
TRIALS (2020)
Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC)
Colin Pawlowski et al.
ELIFE (2020)
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19
Leonard Naymagon et al.
THROMBOSIS RESEARCH (2020)
Thromboembolic Complications in Patients With COVID-19
Gregory Piazza et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia
Claudia Grosse et al.
CARDIOVASCULAR PATHOLOGY (2020)
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance
[Anonymous]
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE (2020)
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study
Alex C. Spyropoulos et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2019)
Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study
K. P. Cohoon et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
Alex C. Spyropoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)
C. Michael Gibson et al.
CIRCULATION (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
J. I. Weitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology
Neville Jackson et al.
EUROPEAN HEART JOURNAL (2016)
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients REPLY
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Benchmarking the Study Initiation Process
Mary Jo Lamberti et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2013)
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Transforming Clinical Trials in Cardiovascular Disease Mission Critical for Health and Economic Well-being
Elliott M. Antman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
Alexander G. G. Turpie et al.
LANCET (2009)
Population pharmacokinetics and pharmacodynamics of once and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement
Lars C. Borris et al.
THROMBOSIS AND HAEMOSTASIS (2008)
分享论文
